Audrey Simonaggio

870 total citations · 1 hit paper
23 papers, 567 citations indexed

About

Audrey Simonaggio is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Audrey Simonaggio has authored 23 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Audrey Simonaggio's work include Cancer Immunotherapy and Biomarkers (15 papers), Renal cell carcinoma treatment (11 papers) and Renal and related cancers (6 papers). Audrey Simonaggio is often cited by papers focused on Cancer Immunotherapy and Biomarkers (15 papers), Renal cell carcinoma treatment (11 papers) and Renal and related cancers (6 papers). Audrey Simonaggio collaborates with scholars based in France, United States and Belgium. Audrey Simonaggio's co-authors include Stéphane Oudard, Yann Vano, Jean‐Marie Michot, Olivier Lambotte, Aurélien Marabelle, Christophe Massard, Stéphane Champiat, Andréa Varga, Aurore Vozy and Ariane Laparra and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Audrey Simonaggio

21 papers receiving 560 citations

Hit Papers

Evaluation of Readministration of Immune Checkpoint Inhib... 2019 2026 2021 2023 2019 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer
    2019 272 citations Audrey Simonaggio, Jean‐Marie Michot et al. JAMA Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Audrey Simonaggio France 10 445 278 104 82 51 23 567
Kuninobu Kanai Japan 10 435 1.0× 316 1.1× 71 0.7× 98 1.2× 61 1.2× 24 622
Jun Sugisaka Japan 8 602 1.4× 287 1.0× 82 0.8× 109 1.3× 36 0.7× 20 680
Yosuke Kawashima Japan 11 605 1.4× 339 1.2× 77 0.7× 112 1.4× 30 0.6× 41 721
Rania Chehade Canada 8 327 0.7× 174 0.6× 125 1.2× 66 0.8× 58 1.1× 21 485
Smitha Menon United States 11 300 0.7× 128 0.5× 134 1.3× 75 0.9× 73 1.4× 18 474
Xiao-Jing Du China 8 497 1.1× 194 0.7× 67 0.6× 103 1.3× 60 1.2× 9 677
Junxun Ma China 18 596 1.3× 373 1.3× 124 1.2× 135 1.6× 82 1.6× 45 796
Giulia Mazzaschi Italy 11 444 1.0× 254 0.9× 130 1.3× 166 2.0× 96 1.9× 54 634
Anika E. Adeni United States 10 560 1.3× 249 0.9× 45 0.4× 161 2.0× 37 0.7× 19 635
Florian Huemer Austria 13 323 0.7× 133 0.5× 114 1.1× 62 0.8× 76 1.5× 46 502

Countries citing papers authored by Audrey Simonaggio

Since Specialization
Citations

This map shows the geographic impact of Audrey Simonaggio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audrey Simonaggio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audrey Simonaggio more than expected).

Fields of papers citing papers by Audrey Simonaggio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Audrey Simonaggio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audrey Simonaggio. The network helps show where Audrey Simonaggio may publish in the future.

Co-authorship network of co-authors of Audrey Simonaggio

This figure shows the co-authorship network connecting the top 25 collaborators of Audrey Simonaggio. A scholar is included among the top collaborators of Audrey Simonaggio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Audrey Simonaggio. Audrey Simonaggio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Daban, A., Laura Phan, Antonin Saldmann, et al.. (2023). Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs). OncoImmunology. 12(1). 2204754–2204754. 21 indexed citations
2.
Vano, Yann, Audrey Simonaggio, Mostefa Bennamoun, et al.. (2023). Overall survival (OS) and efficacy results of second-line treatment in patients (pts) with metastatic clear cell renal cell carcinoma (mRCC) treated in the randomized phase II BIONIKK trial.. Journal of Clinical Oncology. 41(6_suppl). 607–607. 2 indexed citations
3.
Simonaggio, Audrey, et al.. (2022). MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular Insights. International Journal of Molecular Sciences. 23(14). 7649–7649. 19 indexed citations
4.
Simonaggio, Audrey, et al.. (2022). Future treatment options in metastatic clear cell renal cell carcinoma. Bulletin du Cancer. 109(2). 2S47–2S58. 2 indexed citations
5.
Vano, Yann, J. Pouchot, Elizabeth Fabre, et al.. (2022). Preexisting autoantibodies as predictor of immune-related adverse events for advanced solid tumors treated with immune checkpoint inhibitors.. Journal of Clinical Oncology. 40(16_suppl). 2523–2523. 1 indexed citations
6.
Procureur, Adrien, Audrey Simonaggio, Jean‐Emmanuel Bibault, Stéphane Oudard, & Yann Vano. (2021). Enhance the Immune Checkpoint Inhibitors Efficacy with Radiotherapy Induced Immunogenic Cell Death: A Comprehensive Review and Latest Developments. Cancers. 13(4). 678–678. 45 indexed citations
7.
8.
Simonaggio, Audrey, et al.. (2021). Update on the most promising biomarkers of response to immune checkpoint inhibitors in clear cell renal cell carcinoma. World Journal of Urology. 39(5). 1377–1385. 14 indexed citations
9.
Laparra, Ariane, Maria Kfoury, Stéphane Champiat, et al.. (2021). Multiple immune-related toxicities in cancer patients treated with anti-programmed cell death protein 1 immunotherapies: a new surrogate marker for clinical trials?. Annals of Oncology. 32(7). 936–937. 5 indexed citations
10.
Auclin, Édouard, Adrien Procureur, Audrey Simonaggio, et al.. (2020). Cabazitaxel Schedules in Metastatic Castration-Resistant Prostate Cancer: A Review. Future Oncology. 17(1). 91–102. 6 indexed citations
11.
Epaillard, Nicolas, Audrey Simonaggio, Réza Elaidi, et al.. (2020). BIONIKK: A phase 2 biomarker driven trial with nivolumab and ipilimumab or VEGFR tyrosine kinase inhibitor (TKI) in naïve metastatic kidney cancer. Bulletin du Cancer. 107(5). eS22–eS27. 35 indexed citations
12.
Joseph, Adrien, Audrey Simonaggio, Annabelle Stoclin, et al.. (2020). Immune-related adverse events: a retrospective look into the future of oncology in the intensive care unit. Annals of Intensive Care. 10(1). 143–143. 26 indexed citations
13.
Simonaggio, Audrey, Nicolas Epaillard, Réza Elaidi, et al.. (2020). Impact des signatures moléculaires sur le choix du traitement systémique du cancer du rein métastatique. Bulletin du Cancer. 107(5). S24–S34. 4 indexed citations
14.
Moreira, Marco, et al.. (2020). https://cdrjournal.com/article/view/3531. Cancer Drug Resistance. 3(3). 454–471. 14 indexed citations
15.
Simonaggio, Audrey, Réza Elaidi, Laure Fournier, et al.. (2020). Variation in neutrophil to lymphocyte ratio (NLR) as predictor of outcomes in metastatic renal cell carcinoma (mRCC) and non-small cell lung cancer (mNSCLC) patients treated with nivolumab. Cancer Immunology Immunotherapy. 69(12). 2513–2522. 41 indexed citations
16.
Simonaggio, Audrey, Jean‐Marie Michot, Anne Laure Voisin, et al.. (2019). Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer. JAMA Oncology. 5(9). 1310–1310. 272 indexed citations breakdown →
17.
Simonaggio, Audrey, Laure Fournier, Elizabeth Fabre, et al.. (2019). Neutrophil to lymphocyte ratio (NLR) kinetics as predictors of outcomes in metastatic renal cell carcinoma (mRCC) and non-small cell lung cancer (NSCLC) patients treated with nivolumab (N). Annals of Oncology. 30. v511–v511. 2 indexed citations
18.
Vozy, Aurore, Audrey Simonaggio, Philippe Terrier, et al.. (2019). Prognostic factors and therapeutic options for epithelioid hemangioendothelioma (EHE): A multicenter analysis of a series of fifty-seven cases.. Journal of Clinical Oncology. 37(15_suppl). 11062–11062.
19.
Vano, Yann, Audrey Simonaggio, Constance Thibault, & Stéphane Oudard. (2018). Immunothérapie des cancers du rein. Bulletin du Cancer. 105. S24–S34.
20.
Vozy, Aurore, Audrey Simonaggio, Édouard Auclin, et al.. (2018). Applicability of the lung immune prognostic index (LIPI) to metastatic triple negative breast cancer (mTNBC) patients treated with immune checkpoint targeted monoclonal antibodies (ICT mAbs). Annals of Oncology. 29. viii94–viii94. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kuninobu Kanai Breakdown of academic impact, for papers by Jun Sugisaka Breakdown of academic impact, for papers by Yosuke Kawashima Breakdown of academic impact, for papers by Rania Chehade Breakdown of academic impact, for papers by Smitha Menon Breakdown of academic impact, for papers by Xiao-Jing Du Breakdown of academic impact, for papers by Junxun Ma Breakdown of academic impact, for papers by Giulia Mazzaschi Breakdown of academic impact, for papers by Anika E. Adeni Breakdown of academic impact, for papers by Florian Huemer
Rankless by CCL
2026